All In Biotech

Drug Trial Radar · NCT05642312

A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema

Last checked: Nov 20, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 245 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

245

Actual

Start

Jan 9, 2023

Primary completion

Dec 9, 2024

Study completion Jul 9, 2025

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Dec 8, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.

Conditions

  • Uveitic Macular Edema

Interventions

  • VamikibartDrug

    Participants will receive vamikibart IVT injection

  • ShamOther

    Participants will receive a sham procedure that mimics an IVT injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with ≥ 15 letter improvement from baseline in best-corrected visual acuity (BCVA) at Week 16Time frame: Week 16

Locations

77 sites in 14 countries. Site status is shown where the registry gives one.

  • Kaiser Permanente Southern California

    Los Angeles, California

  • Colorado Retina Associates, PC

    Lakewood, Colorado

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida

  • Cumberland Valley Retina PC

    Hagerstown, Maryland

  • VitreoRetinal Surgery, PLLC.

    Minneapolis, Minnesota

  • Truhlsen Eye Institute

    Omaha, Nebraska

  • Envision Ocular, LLC

    Bloomfield, New Jersey

  • Wake Forest Baptist Health Eye Centre

    Winston-Salem, North Carolina

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • The Ohio State University Investigational Drug Services

    Columbus, Ohio

  • Oregon Health & Science Uni

    Portland, Oregon

  • Erie Retina Research

    Erie, Pennsylvania

  • Palmetto Retina Center

    West Columbia, South Carolina

  • Tennessee Retina PC

    Nashville, Tennessee

  • Austin Clinical Research LLC

    Austin, Texas

  • Texas Retina Associates

    Dallas, Texas

  • LKH-Univ.Klinikum Graz

    Graz, Austria

  • Kepler Universitätskliniken GmbH - Med Campus III

    Linz, Austria

  • Medizinische Universitat Wien

    Vienna, Austria

  • Fiocruz - Fundação Oswaldo Cruz

    Rio de Janeiro, Brazil

  • Retina Clinic

    São Paulo, São Paulo, Brazil

  • Universidade Federal de Sao Paulo - UNIFESPX

    São Paulo, São Paulo, Brazil

  • CEMAPE - Centro Médico

    São Paulo, São Paulo, Brazil

  • CHU de Quebec-Universite Laval

    Québec, Canada

  • Kensington Vision and Research Centre

    Toronto, Ontario, Canada

  • Hôpital Maisonneuve - Rosemont

    Montreal, Quebec, Canada

  • Peking Union Medical College Hospital

    Beijing, China

  • Beijing Tongren Hospital

    Beijing, China

  • The Second Hospital of Jilin University

    Changchun, China

  • The First Affiliated Hospital, Chongqing Medical University

    Chongqing, China

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, China

  • Second Affiliated Hospital Zhejiang University College of Medicine

    Hangzhou, China

  • Shanghai First People's Hospital

    Shanghai, China

  • Tianjin Medical University Eye Hospital

    Tianjin, China

  • Eye Hospital, Wenzhou Medical University

    Wenzhou, China

  • Ren Min Hospital Affiliated Wu Han University

    Wuhan, China

  • Rambam Medical Center

    Haifa, Israel

  • Hadassah MC

    Jerusalem, Israel

  • Meir Medical Center

    Kfar Saba, Israel

  • Rabin MC

    Petah Tikva, Israel

Showing 40 of 77 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.